These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
655 related items for PubMed ID: 29844263
1. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies. Ihmaid S. Molecules; 2018 May 29; 23(6):. PubMed ID: 29844263 [Abstract] [Full Text] [Related]
3. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats. Taha M, Imran S, Salahuddin M, Iqbal N, Rahim F, Uddin N, Shehzad A, Khalid Farooq R, Alomari M, Mohammed Khan K. Bioorg Chem; 2021 May 29; 110():104808. PubMed ID: 33756236 [Abstract] [Full Text] [Related]
4. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. Ye GJ, Lan T, Huang ZX, Cheng XN, Cai CY, Ding SM, Xie ML, Wang B. Eur J Med Chem; 2019 Sep 01; 177():362-373. PubMed ID: 31158750 [Abstract] [Full Text] [Related]
5. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation. Li Y, Zhang JH, Xie HX, Ge YX, Wang KM, Song ZL, Zhu KK, Zhang J, Jiang CS. Bioorg Chem; 2021 Dec 01; 117():105423. PubMed ID: 34717239 [Abstract] [Full Text] [Related]
6. Exploring efficacy of natural-derived acetylphenol scaffold inhibitors for α-glucosidase: Synthesis, in vitro and in vivo biochemical studies. Yu X, Zhang F, Liu T, Liu Z, Dong Q, Li D. Bioorg Med Chem Lett; 2020 Dec 01; 30(23):127528. PubMed ID: 32920141 [Abstract] [Full Text] [Related]
7. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. Xie HX, Zhang J, Li Y, Zhang JH, Liu SK, Zhang J, Zheng H, Hao GZ, Zhu KK, Jiang CS. Bioorg Chem; 2021 Oct 01; 115():105236. PubMed ID: 34411978 [Abstract] [Full Text] [Related]
8. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives. Wang G, Chen M, Qiu J, Xie Z, Cao A. Bioorg Med Chem Lett; 2018 Jan 15; 28(2):113-116. PubMed ID: 29208524 [Abstract] [Full Text] [Related]
9. [Synthesis, biological activity and molecular docking research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide derivatives as α-glucosidase inhibitors]. Zhou G, Liang GC, Han XY, Zhong YF, Dong YF, Luo XC, Jin HW, Song YL. Yao Xue Xue Bao; 2016 Jan 15; 51(1):93-9. PubMed ID: 27405168 [Abstract] [Full Text] [Related]
10. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening. Thakral S, Singh V. Med Chem; 2019 Jan 15; 15(2):186-195. PubMed ID: 30251608 [Abstract] [Full Text] [Related]
11. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B. Bioorg Chem; 2018 Oct 15; 80():288-295. PubMed ID: 29980114 [Abstract] [Full Text] [Related]
12. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G, Peng Z, Wang J, Li X, Li J. Eur J Med Chem; 2017 Jan 05; 125():423-429. PubMed ID: 27689725 [Abstract] [Full Text] [Related]
13. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents. Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B. Bioorg Chem; 2018 Apr 05; 77():280-286. PubMed ID: 29421703 [Abstract] [Full Text] [Related]
14. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases. Mughal EU, Hawsawi MB, Naeem N, Hassan A, Alluhaibi MS, Ali Shah SW, Nazir Y, Sadiq A, Alrafai HA, Ahmed SA. Eur J Med Chem; 2024 Jul 05; 273():116523. PubMed ID: 38795518 [Abstract] [Full Text] [Related]
15. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management. Ullah S, Mirza S, Salar U, Hussain S, Javaid K, Khan KM, Khalil R, Atia-Tul-Wahab, Ul-Haq Z, Perveen S, Choudhary MI. Med Chem; 2020 Jul 05; 16(6):826-840. PubMed ID: 31195949 [Abstract] [Full Text] [Related]
16. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors. Gong Z, Xie Z, Qiu J, Wang G. Molecules; 2017 Oct 30; 22(11):. PubMed ID: 29084182 [Abstract] [Full Text] [Related]
17. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase. Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M. Bioorg Chem; 2015 Dec 30; 63():64-71. PubMed ID: 26451651 [Abstract] [Full Text] [Related]
18. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose. Cardullo N, Floresta G, Rescifina A, Muccilli V, Tringali C. Bioorg Chem; 2021 Dec 30; 117():105458. PubMed ID: 34736132 [Abstract] [Full Text] [Related]
19. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites. Sichaem J, Aree T, Lugsanangarm K, Tip-Pyang S. Pharm Biol; 2017 Dec 30; 55(1):1436-1441. PubMed ID: 28320255 [Abstract] [Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors. Wang G, Chen M, Wang J, Peng Y, Li L, Xie Z, Deng B, Chen S, Li W. Bioorg Med Chem Lett; 2017 Jul 01; 27(13):2957-2961. PubMed ID: 28506754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]